122 related articles for article (PubMed ID: 6436192)
21. Interleukin-2 can induce suppression of human natural killer cell cytotoxicity.
Hellstrand K; Hermodsson S
Clin Exp Immunol; 1989 Sep; 77(3):410-6. PubMed ID: 2509116
[TBL] [Abstract][Full Text] [Related]
22. Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.
Seaman WE; Gindhart TD; Blackman MA; Dalal B; Talal N; Werb Z
J Clin Invest; 1982 Apr; 69(4):876-88. PubMed ID: 7076851
[TBL] [Abstract][Full Text] [Related]
23. Monocyte-mediated suppression of IL-2-induced NK-cell activation. Regulation by 5-HT1A-type serotonin receptors.
Hellstrand K; Hermodsson S
Scand J Immunol; 1990 Aug; 32(2):183-92. PubMed ID: 2117776
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2.
Leung KH
Cell Immunol; 1989 Oct; 123(2):384-95. PubMed ID: 2507171
[TBL] [Abstract][Full Text] [Related]
25. Modulation of natural killing by cyclo- and lipo-oxygenase inhibitors.
Villa ML; Valenti F; Mantovani M
Immunology; 1988 Jan; 63(1):93-7. PubMed ID: 3123373
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the in vitro effect of triethylphosphine gold (auranofin) on human NK cell activity.
Pedersen BK; Abom B
Clin Exp Rheumatol; 1986; 4(3):249-53. PubMed ID: 3490341
[TBL] [Abstract][Full Text] [Related]
27. Cadmium inhibits spontaneous (NK), antibody-mediated (ADCC) and IL-2-stimulated cytotoxic functions of natural killer cells.
Cifone MG; Procopio A; Napolitano T; Alesse E; Santoni G; Santoni A
Immunopharmacology; 1990; 20(2):73-80. PubMed ID: 2266002
[TBL] [Abstract][Full Text] [Related]
28. Reduced natural killer activity in female mice after neonatal exposure to diethylstilbestrol.
Kalland T
J Immunol; 1980 Mar; 124(3):1297-300. PubMed ID: 7358984
[TBL] [Abstract][Full Text] [Related]
29. Natural killer cell activity and tumor susceptibility in female mice treated neonatally with diethylstilbestrol.
Kalland T; Forsberg JG
Cancer Res; 1981 Dec; 41(12 Pt 1):5134-40. PubMed ID: 7307011
[TBL] [Abstract][Full Text] [Related]
30. Activation of natural killer cell cytotoxicity of human blood monocytes by a low molecular weight component from viscum album extract.
Klett CY; Anderer FA
Arzneimittelforschung; 1989 Dec; 39(12):1580-5. PubMed ID: 2624609
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulation of human natural killer cell cytotoxic function by triazine and carbamate pesticides.
Whalen MM; Loganathan BG; Yamashita N; Saito T
Chem Biol Interact; 2003 Jun; 145(3):311-9. PubMed ID: 12732457
[TBL] [Abstract][Full Text] [Related]
32. Indomethacin inhibits circulating PGE2 and reverses postexercise suppression of natural killer cell activity.
Rhind SG; Gannon GA; Suzui M; Shephard RJ; Shek PN
Am J Physiol; 1999 May; 276(5):R1496-505. PubMed ID: 10233044
[TBL] [Abstract][Full Text] [Related]
33. Reversible inhibition of natural killer cell activity by volatile anaesthetic agents in vitro.
Woods GM; Griffiths DM
Br J Anaesth; 1986 May; 58(5):535-9. PubMed ID: 3457589
[TBL] [Abstract][Full Text] [Related]
34. Modulation of natural killer activity by aspirin: I. In vitro effect of aspirin.
Porzsolt F; Wolf W
J Interferon Res; 1983; 3(1):11-7. PubMed ID: 6842038
[TBL] [Abstract][Full Text] [Related]
35. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency.
Allen JI; Perri RT; McClain CJ; Kay NE
J Lab Clin Med; 1983 Oct; 102(4):577-89. PubMed ID: 6604771
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of NK cell-induced cytolysis by thiocarbamide antithyroid drugs.
Ferguson MM; McDonald FG; Alexander WD
Immunol Lett; 1985; 11(2):117-20. PubMed ID: 3866747
[TBL] [Abstract][Full Text] [Related]
37. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
38. Human natural killer cell activity is reversibly inhibited by antagonists of lipoxygenation.
Seaman WE
J Immunol; 1983 Dec; 131(6):2953-7. PubMed ID: 6417236
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human natural killer cell and lymphokine-activated killer cell cytotoxicity and differentiation by vitamin D3.
Leung KH
Scand J Immunol; 1989 Aug; 30(2):199-208. PubMed ID: 2548278
[TBL] [Abstract][Full Text] [Related]
40. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
Sibbitt WL; Mathews PM; Bankhurst AD
J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
